Biosimilar

White House Unveils Plan to Lower Cost of Prescription Drugs

White House Unveils Plan to Lower Cost of Prescription Drugs

By

FDA Commissioner, Scott Gottlieb MD, said, "The FDA shares the goal of ensuring that American patients have access to quality and affordable care that meets their needs."

Concern Regarding Legislation Allowing Substitution of Biosimilars for Branded Drugs

Concern Regarding Legislation Allowing Substitution of Biosimilars for Branded Drugs

Much concern has been voiced regarding legislation allowing the substitution of biosimilars for branded drugs.

Sign Up for Free e-Newsletters